Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Yijing Fang (also known as Bushen Yijing formula or granules) is a Traditional Chinese Medicine (TCM) herbal formulation developed by researchers at Shanghai Shuguang Hospital. It is designed to treat bone metabolism disorders by 'tonifying the kidney and replenishing essence,' a concept in TCM linked to skeletal health. The formula is primarily investigated for its ability to increase bone mineral density and reduce the risk of hip fractures in postmenopausal women with osteopenia or primary osteoporosis. Clinical evidence includes a 36-month randomized, double-blind, placebo-controlled trial demonstrating its efficacy in reducing fracture risk factors when used alongside calcium supplementation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bushen yijing fang.